Sucampo Pharma (SCMP) Sees Weakness

November 2, 2016 11:55 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Sucampo Pharma (NASDAQ: SCMP) is weak as Blue Cross/Blue Shield ot Texas drops Amitiza from coverage list. LINK



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment